Patents Assigned to Origent Data Sciences, Inc.
  • Patent number: 12633383
    Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.
    Type: Grant
    Filed: June 4, 2024
    Date of Patent: May 19, 2026
    Assignee: Origent Data Sciences, Inc.
    Inventors: David L. Ennist, Albert A. Taylor, Danielle E. Beaulieu, Michael A. Keymer
  • Publication number: 20250069710
    Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.
    Type: Application
    Filed: June 4, 2024
    Publication date: February 27, 2025
    Applicant: Origent Data Sciences, Inc.
    Inventors: David L. ENNIST, Albert A. TAYLOR, Danielle E. BEAULIEU, Michael A. KEYMER
  • Patent number: 12002553
    Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.
    Type: Grant
    Filed: October 4, 2021
    Date of Patent: June 4, 2024
    Assignee: Origent Data Sciences, Inc.
    Inventors: David L. Ennist, Albert A. Taylor, Danielle E. Beaulieu, Michael A. Keymer
  • Publication number: 20220139505
    Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.
    Type: Application
    Filed: October 4, 2021
    Publication date: May 5, 2022
    Applicant: Origent Data Sciences, Inc.
    Inventors: David L. ENNIST, Albert A. TAYLOR, Danielle E. BEAULIEU, Michael A. KEYMER
  • Patent number: 11139051
    Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: October 5, 2021
    Assignee: Origent Data Sciences, Inc.
    Inventors: David L. Ennist, Albert A. Taylor, Danielle E. Beaulieu, Michael A. Keymer
  • Publication number: 20200105380
    Abstract: A method for enrolling patient candidates in a clinical trial includes generating first prediction data indicating predicted progression of a condition for a first group of patients that participated in a first clinical trial using a predictive model and clinical data associated with the first group of patients; grouping clinical trial data into subsets based on the first prediction data; analyzing each subset of clinical trial data to generate a measure of efficacy of the treatment; establishing screening criteria for a second clinical trial by identifying at least one subset that has a measure of efficacy that is higher than a measure of efficacy of the treatment for the full first group of patients; receiving clinical data of a candidate for the second clinical trial; generating second prediction data for the candidate; and enrolling the candidate in the second clinical trial when the second prediction data satisfies the screening criteria.
    Type: Application
    Filed: October 2, 2018
    Publication date: April 2, 2020
    Applicant: Origent Data Sciences, Inc.
    Inventors: David L. ENNIST, Albert A. TAYLOR, Danielle E. BEAULIEU, Michael A. KEYMER